DXPP
Live / Registered — Registered (as of 22 Apr 2025)
What this means for you
Registered since 22 Apr 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Apr 2031: the §8 declaration of use).
Record
- Serial number
- 97877454
- Registration number
- 7770975
- Mark type
- Word mark
- Filed
- 07 Apr 2023
- Published for opposition
- 06 Feb 2024
- Registered
- 22 Apr 2025
- Next maintenance filing
- §8 declaration of use, due by 22 Apr 2031 (grace period to 22 Oct 2031)
- Attorney of record
- Patricia L. Cotton
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; Providing laboratory research services in the field of gene expression, namely, cancer biology
Owner
- First Ascent Biomedical Inc., Miami, FL, US
- First Ascent Biomedical Inc., Miami, FL, US
- First Ascent Biomedical Inc., Miami, FL, US
Prosecution history
- 11 Nov 2025 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 22 Oct 2025 — CORRECTION UNDER SECTION 7 - PROCESSED
- 20 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Jul 2025 — TEAS SECTION 7 REQUEST RECEIVED
- 22 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 02 Apr 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Apr 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Apr 2025 — EXAMINER'S AMENDMENT ENTERED
- 02 Apr 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Apr 2025 — EXAMINERS AMENDMENT E-MAILED
- 02 Apr 2025 — SU-EXAMINER'S AMENDMENT WRITTEN
- 13 Dec 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 13 Dec 2024 — FINAL REFUSAL E-MAILED
- 13 Dec 2024 — SU - FINAL REFUSAL - WRITTEN